![]() The PAMI risk score, with a range of 0 to 15 points, was found to be a strong predictor of late mortality in STEMI patient undergoing primary percutaneous coronary intervention (PCI). The Primary Angioplasty in Myocardial Infarction (PAMI) score is based on clinical and electrocardiographic characteristics. The second most used score is the Global Registry of Acute Coronary Events (GRACE) risk model, which uses eight variables and is applicable to the entire spectrum of ACS. For ST-segment elevation myocardial infarction (STEMI) patients, the TIMI score is based on eight clinical indicators available upon admission, with scores ranging from 0 to 14. The most widely used risk score is the Thrombolysis In Myocardial Infarction (TIMI) algorithm, which is simple to calculate and is derived from selected clinical-trial cohorts. Several risk scores have been developed in the last 20 years to stratify patients hospitalized with ACS. This study was conducted to determine accurate risk stratification in the management of ACS patients with DM. To improve ACS-related mortality and morbidity in Taiwan, the Acute Coronary Syndrome-Diabetes Mellitus Registry of the Taiwan Society of Cardiology (TSOC ACS-DM Registry) was established to assess the quality of care for ACS patients with DM. In Taiwan, acute coronary syndrome (ACS) patients with diabetes had significantly worse outcomes than those without DM, including all-cause death and combined results for death, re-infarction, and stroke. It also had the best predictive value for in-hospital bleeding and acute renal failure.ĭiabetes mellitus (DM) is associated with poor outcomes in patients with coronary artery disease (CAD). In conclusion, the CADILLAC risk score is more effective than other risk scores in predicting 6-month, 1-year, and 2-year all-cause mortality in diabetic patients with STEMI. The CADILLAC score had the best discriminative accuracy, with an AUC of 0.8207 (p8 had poorer 2-year survival than those with lower scores (log-rank p<0.0001). In the 455 patients included, all four risk score systems demonstrated predictive accuracy for 6-, 12- and 24-month mortality with AUC values of 0.67–0.82. The discriminative potential of risk scores was analyzed using the area under the receiver-operating characteristics curve (AUC). The TIMI, GRACE, PAMI, and CADILLAC risk scores were calculated. From the Acute Coronary Syndrome-Diabetes Mellitus Registry of the Taiwan Society of Cardiology, patients with STEMI were included. This study aimed to compare the performance of The Thrombolysis In Myocardial Infarction (TIMI), Global Registry of Acute Coronary Events (GRACE), Primary Angioplasty in Myocardial Infarction (PAMI), and Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) risk scores in predicting long-term cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction (STEMI). Acute coronary syndrome (ACS) patients with diabetes have significantly worse cardiovascular outcomes than those without diabetes.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |